XML 76 R53.htm IDEA: XBRL DOCUMENT

Other Financial Assets (Tables)

12 Months Ended

Mar. 31, 2018

Disclosure Of Financial Assets [Abstract]

Summary of Changes in Other Financial Assets

The following table outlines changes in other financial assets. Additional details on how fair value is calculated is included in Note 28.

								Balance at																				Balance at
						Accounting		March 31,																Interest				March 31,
Entity		Instrument		Note		method		2017				Additions				FVTOCI¹				FVTPL				revenue				2018
TerrAscend		warrants		15(i)		FVTPL		$	-			$	7,540			$	-			$	67,614			$	-			$	75,154
AusCann		shares		16(i)		FVOCI			18,328				1,214				19,544				-				-				39,086
AusCann		options		16(i)		FVTPL			5,702				-				-				4,785				-				10,487
JWC		shares		16(ii)		FVTOCI			-				3,863				6,728				-				-				10,591
JWC		warrants		16(ii)		FVTPL							112								702				-				814
JWC		royalty interest		16(ii)		amortized cost			-				2,500				-				-				162				2,662
Agripharm		royalty interest		10(c)		amortized cost			-				2,414				-				-				(88	)			2,326
Agripharm		warrants		10(c)		FVTPL			-				586				-				(139	)			-				447
Vapium		shares		16(iii)		cost			-				1,210				-				-				-				1,210
Radicle		repayable debenture		15(ii)		amortized cost			-				3,000				-				-				75				3,075
HydRx		shares		16(iv)		FVTOCI							-				12,401				-				-				12,401
HydRx		warrants		16(iv)		FVTPL			-				-				-				5,210				-				5,210
								$	24,030			$	22,439			$	38,673			$	78,172			$	149			$	163,463

¹ Changes in fair value through other comprehensive income (“FVTOCI”)